Article Text

Download PDFPDF

Original article
Open-source mobile digital platform for clinical trial data collection in low-resource settings
  1. Joris van Dam1,
  2. Kevin Omondi Onyango2,
  3. Brian Midamba2,
  4. Nele Groosman3,
  5. Norman Hooper3,
  6. Jonathan Spector1,
  7. Goonaseelan (Colin) Pillai4,
  8. Bernhards Ogutu2
  1. 1Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA
  2. 2Kenya Medical Research Institutes and Center for Research in Therapeutic Sciences Strathmore University, Nairobi, Kenya
  3. 3Dimagi, Cape Town, South Africa
  4. 4Novartis AG, Basel, Switzerland
  1. Correspondence to Joris van Dam, Novartis Institutes for BioMedical Research, 250 Massachussetts Ave, Cambridge, Massachusetts 02139-4133, USA; joris.vandam{at}novartis.com

Footnotes

  • Contributors JvD, KOO, NH, JS, GP and BO were involved in conception or design of the work. KOO, BM, NG, NH and BO collected the data. KOO, BM, NG, NH and GP analysed and interpreted the data. JvD, KOO, BM, NG and NH drafted the article. JS, GP and BO critically revised the article. JvD, KOO, BM, NG, NH, JS, GP and BO approved the final version of the article to be published.

  • Funding Novartis Institutes for BioMedical Research, Investigator Initiated Trial Agreement, dated October 2014.

  • Competing interests NG and NH are employees of Dimagi , the company that developed the CommCare platform. JvD, JS and CP are employees of Novartis.

  • Ethics approval KEMRI SERU (Scientific and Ethics Review Unit).

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors JvD, KOO, NH, JS, GP and BO were involved in conception or design of the work. KOO, BM, NG, NH and BO collected the data. KOO, BM, NG, NH and GP analysed and interpreted the data. JvD, KOO, BM, NG and NH drafted the article. JS, GP and BO critically revised the article. JvD, KOO, BM, NG, NH, JS, GP and BO approved the final version of the article to be published.

  • Funding Novartis Institutes for BioMedical Research, Investigator Initiated Trial Agreement, dated October 2014.

  • Competing interests NG and NH are employees of Dimagi , the company that developed the CommCare platform. JvD, JS and CP are employees of Novartis.

  • Ethics approval KEMRI SERU (Scientific and Ethics Review Unit).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.